nodes	percent_of_prediction	percent_of_DWPC	metapath
Zaleplon—CYP3A7—Rifampicin—leprosy	0.129	0.158	CbGbCtD
Zaleplon—CYP3A7-CYP3A51P—Rifampicin—leprosy	0.129	0.158	CbGbCtD
Zaleplon—CYP3A7—Dapsone—leprosy	0.106	0.13	CbGbCtD
Zaleplon—CYP3A7-CYP3A51P—Dapsone—leprosy	0.106	0.13	CbGbCtD
Zaleplon—CYP3A5—Thalidomide—leprosy	0.0998	0.122	CbGbCtD
Zaleplon—CYP3A5—Rifampicin—leprosy	0.0967	0.119	CbGbCtD
Zaleplon—CYP3A5—Dapsone—leprosy	0.0798	0.0978	CbGbCtD
Zaleplon—CYP3A4—Rifampicin—leprosy	0.0377	0.0462	CbGbCtD
Zaleplon—CYP3A4—Dapsone—leprosy	0.0311	0.0382	CbGbCtD
Zaleplon—Menopause—Thalidomide—leprosy	0.00547	0.0305	CcSEcCtD
Zaleplon—Hangover—Thalidomide—leprosy	0.00527	0.0294	CcSEcCtD
Zaleplon—Circumoral paresthesia—Thalidomide—leprosy	0.00381	0.0213	CcSEcCtD
Zaleplon—Albuminuria—Dapsone—leprosy	0.00325	0.0181	CcSEcCtD
Zaleplon—Hyporeflexia—Thalidomide—leprosy	0.00273	0.0152	CcSEcCtD
Zaleplon—Aphthous stomatitis—Thalidomide—leprosy	0.00265	0.0148	CcSEcCtD
Zaleplon—Paraesthesia oral—Thalidomide—leprosy	0.00265	0.0148	CcSEcCtD
Zaleplon—Neck stiffness—Thalidomide—leprosy	0.00261	0.0145	CcSEcCtD
Zaleplon—Tongue discolouration—Thalidomide—leprosy	0.00257	0.0143	CcSEcCtD
Zaleplon—Cerebral ischaemia—Thalidomide—leprosy	0.00257	0.0143	CcSEcCtD
Zaleplon—Sinus bradycardia—Thalidomide—leprosy	0.00253	0.0141	CcSEcCtD
Zaleplon—Nuchal rigidity—Thalidomide—leprosy	0.00239	0.0134	CcSEcCtD
Zaleplon—Hostility—Thalidomide—leprosy	0.00224	0.0125	CcSEcCtD
Zaleplon—Vesiculobullous rash—Thalidomide—leprosy	0.00221	0.0124	CcSEcCtD
Zaleplon—Psoriasis—Thalidomide—leprosy	0.00197	0.011	CcSEcCtD
Zaleplon—Myasthenia—Thalidomide—leprosy	0.00197	0.011	CcSEcCtD
Zaleplon—Hypothyroidism—Thalidomide—leprosy	0.00193	0.0108	CcSEcCtD
Zaleplon—Intestinal obstruction—Thalidomide—leprosy	0.00182	0.0102	CcSEcCtD
Zaleplon—Neuralgia—Thalidomide—leprosy	0.00179	0.00997	CcSEcCtD
Zaleplon—Cyanosis—Thalidomide—leprosy	0.00175	0.00979	CcSEcCtD
Zaleplon—Nystagmus—Thalidomide—leprosy	0.00174	0.0097	CcSEcCtD
Zaleplon—Metrorrhagia—Thalidomide—leprosy	0.00174	0.0097	CcSEcCtD
Zaleplon—Psychotic disorder—Dapsone—leprosy	0.00172	0.00959	CcSEcCtD
Zaleplon—Stupor—Thalidomide—leprosy	0.00166	0.00928	CcSEcCtD
Zaleplon—Albuminuria—Thalidomide—leprosy	0.00166	0.00928	CcSEcCtD
Zaleplon—Pleural effusion—Thalidomide—leprosy	0.00162	0.00905	CcSEcCtD
Zaleplon—Hyperaesthesia—Thalidomide—leprosy	0.00158	0.00883	CcSEcCtD
Zaleplon—Rash pustular—Thalidomide—leprosy	0.00156	0.00869	CcSEcCtD
Zaleplon—Muscular weakness—Dapsone—leprosy	0.00155	0.00866	CcSEcCtD
Zaleplon—Apnoea—Thalidomide—leprosy	0.00146	0.00817	CcSEcCtD
Zaleplon—Photosensitivity reaction—Dapsone—leprosy	0.00139	0.00775	CcSEcCtD
Zaleplon—Musculoskeletal stiffness—Thalidomide—leprosy	0.00138	0.00772	CcSEcCtD
Zaleplon—Skin discolouration—Thalidomide—leprosy	0.00137	0.00767	CcSEcCtD
Zaleplon—Arthropathy—Thalidomide—leprosy	0.00136	0.00762	CcSEcCtD
Zaleplon—Hyperbilirubinaemia—Thalidomide—leprosy	0.00136	0.00762	CcSEcCtD
Zaleplon—Thinking abnormal—Thalidomide—leprosy	0.00136	0.00757	CcSEcCtD
Zaleplon—Hyperuricaemia—Thalidomide—leprosy	0.00134	0.00747	CcSEcCtD
Zaleplon—Neuropathy peripheral—Dapsone—leprosy	0.00133	0.00742	CcSEcCtD
Zaleplon—Leukocytosis—Thalidomide—leprosy	0.00132	0.00737	CcSEcCtD
Zaleplon—Hypercholesterolaemia—Thalidomide—leprosy	0.00131	0.00732	CcSEcCtD
Zaleplon—Gait disturbance—Thalidomide—leprosy	0.00127	0.0071	CcSEcCtD
Zaleplon—Coordination abnormal—Thalidomide—leprosy	0.00126	0.00705	CcSEcCtD
Zaleplon—Blood uric acid increased—Thalidomide—leprosy	0.00126	0.00705	CcSEcCtD
Zaleplon—Pulmonary embolism—Thalidomide—leprosy	0.00124	0.00693	CcSEcCtD
Zaleplon—Eructation—Thalidomide—leprosy	0.00122	0.00681	CcSEcCtD
Zaleplon—Depressed level of consciousness—Thalidomide—leprosy	0.0012	0.00669	CcSEcCtD
Zaleplon—Colitis—Thalidomide—leprosy	0.00119	0.00665	CcSEcCtD
Zaleplon—Neuropathy—Thalidomide—leprosy	0.00117	0.0065	CcSEcCtD
Zaleplon—Dry eye—Thalidomide—leprosy	0.00115	0.0064	CcSEcCtD
Zaleplon—Tinnitus—Dapsone—leprosy	0.00114	0.00634	CcSEcCtD
Zaleplon—Oesophagitis—Thalidomide—leprosy	0.00113	0.00633	CcSEcCtD
Zaleplon—Rash maculo-papular—Thalidomide—leprosy	0.00113	0.0063	CcSEcCtD
Zaleplon—Hypertonia—Thalidomide—leprosy	0.00109	0.00607	CcSEcCtD
Zaleplon—Hyperkinesia—Thalidomide—leprosy	0.00108	0.00604	CcSEcCtD
Zaleplon—Mental disability—Thalidomide—leprosy	0.00108	0.00601	CcSEcCtD
Zaleplon—Euphoric mood—Thalidomide—leprosy	0.00107	0.00595	CcSEcCtD
Zaleplon—Lymphadenopathy—Thalidomide—leprosy	0.00106	0.00589	CcSEcCtD
Zaleplon—Thrombophlebitis—Thalidomide—leprosy	0.00104	0.00581	CcSEcCtD
Zaleplon—Diabetes mellitus—Thalidomide—leprosy	0.00104	0.00578	CcSEcCtD
Zaleplon—Photosensitivity—Thalidomide—leprosy	0.00103	0.00573	CcSEcCtD
Zaleplon—Gastroenteritis—Thalidomide—leprosy	0.00102	0.00567	CcSEcCtD
Zaleplon—Vascular purpura—Thalidomide—leprosy	0.00101	0.00562	CcSEcCtD
Zaleplon—Deafness—Thalidomide—leprosy	0.00101	0.00562	CcSEcCtD
Zaleplon—Eczema—Thalidomide—leprosy	0.001	0.0056	CcSEcCtD
Zaleplon—Eye pain—Thalidomide—leprosy	0.000998	0.00557	CcSEcCtD
Zaleplon—Libido decreased—Thalidomide—leprosy	0.000971	0.00542	CcSEcCtD
Zaleplon—Increased appetite—Thalidomide—leprosy	0.000959	0.00535	CcSEcCtD
Zaleplon—Amnesia—Thalidomide—leprosy	0.000959	0.00535	CcSEcCtD
Zaleplon—TSPO—hindlimb—leprosy	0.000955	0.191	CbGeAlD
Zaleplon—Vertigo—Dapsone—leprosy	0.000952	0.00531	CcSEcCtD
Zaleplon—Dermatitis bullous—Thalidomide—leprosy	0.000943	0.00526	CcSEcCtD
Zaleplon—Purpura—Thalidomide—leprosy	0.000935	0.00522	CcSEcCtD
Zaleplon—Arthritis—Thalidomide—leprosy	0.000927	0.00517	CcSEcCtD
Zaleplon—Hypoglycaemia—Thalidomide—leprosy	0.000923	0.00515	CcSEcCtD
Zaleplon—Osteoarthritis—Thalidomide—leprosy	0.000901	0.00503	CcSEcCtD
Zaleplon—Diplopia—Thalidomide—leprosy	0.000901	0.00503	CcSEcCtD
Zaleplon—Disturbance in sexual arousal—Thalidomide—leprosy	0.000894	0.00499	CcSEcCtD
Zaleplon—Migraine—Thalidomide—leprosy	0.000887	0.00495	CcSEcCtD
Zaleplon—Affect lability—Thalidomide—leprosy	0.000887	0.00495	CcSEcCtD
Zaleplon—Psychotic disorder—Thalidomide—leprosy	0.00088	0.00491	CcSEcCtD
Zaleplon—Face oedema—Thalidomide—leprosy	0.00087	0.00485	CcSEcCtD
Zaleplon—Mood swings—Thalidomide—leprosy	0.000853	0.00476	CcSEcCtD
Zaleplon—Ataxia—Thalidomide—leprosy	0.000847	0.00473	CcSEcCtD
Zaleplon—Tachycardia—Dapsone—leprosy	0.000844	0.00471	CcSEcCtD
Zaleplon—Liver function test abnormal—Thalidomide—leprosy	0.000832	0.00464	CcSEcCtD
Zaleplon—Dry skin—Thalidomide—leprosy	0.000826	0.00461	CcSEcCtD
Zaleplon—Orthostatic hypotension—Thalidomide—leprosy	0.000823	0.00459	CcSEcCtD
Zaleplon—TSPO—appendage—leprosy	0.00082	0.164	CbGeAlD
Zaleplon—Breast disorder—Thalidomide—leprosy	0.000814	0.00454	CcSEcCtD
Zaleplon—Aspartate aminotransferase increased—Thalidomide—leprosy	0.000811	0.00453	CcSEcCtD
Zaleplon—Muscular weakness—Thalidomide—leprosy	0.000795	0.00444	CcSEcCtD
Zaleplon—Alanine aminotransferase increased—Thalidomide—leprosy	0.000795	0.00444	CcSEcCtD
Zaleplon—Insomnia—Dapsone—leprosy	0.000782	0.00437	CcSEcCtD
Zaleplon—Dysphagia—Thalidomide—leprosy	0.000779	0.00435	CcSEcCtD
Zaleplon—Eosinophilia—Thalidomide—leprosy	0.000771	0.0043	CcSEcCtD
Zaleplon—Angina pectoris—Thalidomide—leprosy	0.000758	0.00423	CcSEcCtD
Zaleplon—Bronchitis—Thalidomide—leprosy	0.000749	0.00418	CcSEcCtD
Zaleplon—Pollakiuria—Thalidomide—leprosy	0.000719	0.00401	CcSEcCtD
Zaleplon—Erectile dysfunction—Thalidomide—leprosy	0.000717	0.004	CcSEcCtD
Zaleplon—Photosensitivity reaction—Thalidomide—leprosy	0.000711	0.00397	CcSEcCtD
Zaleplon—Weight increased—Thalidomide—leprosy	0.000709	0.00396	CcSEcCtD
Zaleplon—Gastrointestinal pain—Dapsone—leprosy	0.000707	0.00395	CcSEcCtD
Zaleplon—Weight decreased—Thalidomide—leprosy	0.000704	0.00393	CcSEcCtD
Zaleplon—Hyperglycaemia—Thalidomide—leprosy	0.000702	0.00392	CcSEcCtD
Zaleplon—Pneumonia—Thalidomide—leprosy	0.000698	0.0039	CcSEcCtD
Zaleplon—Depression—Thalidomide—leprosy	0.000692	0.00386	CcSEcCtD
Zaleplon—Body temperature increased—Dapsone—leprosy	0.000684	0.00382	CcSEcCtD
Zaleplon—Abdominal pain—Dapsone—leprosy	0.000684	0.00382	CcSEcCtD
Zaleplon—Neuropathy peripheral—Thalidomide—leprosy	0.000681	0.0038	CcSEcCtD
Zaleplon—Stomatitis—Thalidomide—leprosy	0.000677	0.00378	CcSEcCtD
Zaleplon—Conjunctivitis—Thalidomide—leprosy	0.000675	0.00377	CcSEcCtD
Zaleplon—Sweating—Thalidomide—leprosy	0.000666	0.00372	CcSEcCtD
Zaleplon—Haematuria—Thalidomide—leprosy	0.000662	0.00369	CcSEcCtD
Zaleplon—Epistaxis—Thalidomide—leprosy	0.000655	0.00366	CcSEcCtD
Zaleplon—Hypoaesthesia—Thalidomide—leprosy	0.00062	0.00346	CcSEcCtD
Zaleplon—Oedema peripheral—Thalidomide—leprosy	0.000614	0.00343	CcSEcCtD
Zaleplon—Visual impairment—Thalidomide—leprosy	0.000601	0.00335	CcSEcCtD
Zaleplon—Eye disorder—Thalidomide—leprosy	0.000582	0.00325	CcSEcCtD
Zaleplon—Tinnitus—Thalidomide—leprosy	0.000581	0.00324	CcSEcCtD
Zaleplon—Immune system disorder—Thalidomide—leprosy	0.000563	0.00314	CcSEcCtD
Zaleplon—Chills—Thalidomide—leprosy	0.000559	0.00312	CcSEcCtD
Zaleplon—Alopecia—Thalidomide—leprosy	0.000551	0.00307	CcSEcCtD
Zaleplon—Mental disorder—Thalidomide—leprosy	0.000546	0.00305	CcSEcCtD
Zaleplon—Malnutrition—Thalidomide—leprosy	0.000543	0.00303	CcSEcCtD
Zaleplon—Headache—Dapsone—leprosy	0.000542	0.00302	CcSEcCtD
Zaleplon—Flatulence—Thalidomide—leprosy	0.000535	0.00298	CcSEcCtD
Zaleplon—Tension—Thalidomide—leprosy	0.000532	0.00297	CcSEcCtD
Zaleplon—Dysgeusia—Thalidomide—leprosy	0.000531	0.00297	CcSEcCtD
Zaleplon—Nervousness—Thalidomide—leprosy	0.000527	0.00294	CcSEcCtD
Zaleplon—Back pain—Thalidomide—leprosy	0.000525	0.00293	CcSEcCtD
Zaleplon—Nausea—Dapsone—leprosy	0.000514	0.00287	CcSEcCtD
Zaleplon—Tremor—Thalidomide—leprosy	0.000508	0.00284	CcSEcCtD
Zaleplon—Ill-defined disorder—Thalidomide—leprosy	0.000503	0.00281	CcSEcCtD
Zaleplon—Anaemia—Thalidomide—leprosy	0.000501	0.0028	CcSEcCtD
Zaleplon—Agitation—Thalidomide—leprosy	0.000499	0.00278	CcSEcCtD
Zaleplon—Angioedema—Thalidomide—leprosy	0.000496	0.00277	CcSEcCtD
Zaleplon—Malaise—Thalidomide—leprosy	0.000489	0.00273	CcSEcCtD
Zaleplon—Vertigo—Thalidomide—leprosy	0.000487	0.00272	CcSEcCtD
Zaleplon—Syncope—Thalidomide—leprosy	0.000487	0.00272	CcSEcCtD
Zaleplon—Palpitations—Thalidomide—leprosy	0.000479	0.00268	CcSEcCtD
Zaleplon—Loss of consciousness—Thalidomide—leprosy	0.000477	0.00266	CcSEcCtD
Zaleplon—Hypertension—Thalidomide—leprosy	0.000468	0.00261	CcSEcCtD
Zaleplon—Arthralgia—Thalidomide—leprosy	0.000462	0.00258	CcSEcCtD
Zaleplon—Chest pain—Thalidomide—leprosy	0.000462	0.00258	CcSEcCtD
Zaleplon—Myalgia—Thalidomide—leprosy	0.000462	0.00258	CcSEcCtD
Zaleplon—Anxiety—Thalidomide—leprosy	0.00046	0.00257	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000459	0.00256	CcSEcCtD
Zaleplon—Discomfort—Thalidomide—leprosy	0.000456	0.00255	CcSEcCtD
Zaleplon—TSPO—blood vessel—leprosy	0.000456	0.0912	CbGeAlD
Zaleplon—Dry mouth—Thalidomide—leprosy	0.000452	0.00252	CcSEcCtD
Zaleplon—Confusional state—Thalidomide—leprosy	0.000446	0.00249	CcSEcCtD
Zaleplon—Oedema—Thalidomide—leprosy	0.000443	0.00247	CcSEcCtD
Zaleplon—Shock—Thalidomide—leprosy	0.000436	0.00243	CcSEcCtD
Zaleplon—Nervous system disorder—Thalidomide—leprosy	0.000434	0.00242	CcSEcCtD
Zaleplon—Tachycardia—Thalidomide—leprosy	0.000432	0.00241	CcSEcCtD
Zaleplon—Skin disorder—Thalidomide—leprosy	0.00043	0.0024	CcSEcCtD
Zaleplon—Hyperhidrosis—Thalidomide—leprosy	0.000428	0.00239	CcSEcCtD
Zaleplon—Anorexia—Thalidomide—leprosy	0.000422	0.00236	CcSEcCtD
Zaleplon—Hypotension—Thalidomide—leprosy	0.000414	0.00231	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Thalidomide—leprosy	0.000403	0.00225	CcSEcCtD
Zaleplon—Insomnia—Thalidomide—leprosy	0.0004	0.00224	CcSEcCtD
Zaleplon—Paraesthesia—Thalidomide—leprosy	0.000398	0.00222	CcSEcCtD
Zaleplon—Dyspnoea—Thalidomide—leprosy	0.000395	0.0022	CcSEcCtD
Zaleplon—Somnolence—Thalidomide—leprosy	0.000394	0.0022	CcSEcCtD
Zaleplon—Dyspepsia—Thalidomide—leprosy	0.00039	0.00218	CcSEcCtD
Zaleplon—Decreased appetite—Thalidomide—leprosy	0.000385	0.00215	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Thalidomide—leprosy	0.000382	0.00213	CcSEcCtD
Zaleplon—Pain—Thalidomide—leprosy	0.000379	0.00211	CcSEcCtD
Zaleplon—Constipation—Thalidomide—leprosy	0.000379	0.00211	CcSEcCtD
Zaleplon—Feeling abnormal—Thalidomide—leprosy	0.000365	0.00204	CcSEcCtD
Zaleplon—Gastrointestinal pain—Thalidomide—leprosy	0.000362	0.00202	CcSEcCtD
Zaleplon—Urticaria—Thalidomide—leprosy	0.000352	0.00196	CcSEcCtD
Zaleplon—Abdominal pain—Thalidomide—leprosy	0.00035	0.00195	CcSEcCtD
Zaleplon—Body temperature increased—Thalidomide—leprosy	0.00035	0.00195	CcSEcCtD
Zaleplon—Asthenia—Thalidomide—leprosy	0.000318	0.00177	CcSEcCtD
Zaleplon—Pruritus—Thalidomide—leprosy	0.000313	0.00175	CcSEcCtD
Zaleplon—Dizziness—Thalidomide—leprosy	0.000293	0.00163	CcSEcCtD
Zaleplon—AOX1—eye—leprosy	0.000284	0.0568	CbGeAlD
Zaleplon—Rash—Thalidomide—leprosy	0.000279	0.00156	CcSEcCtD
Zaleplon—Dermatitis—Thalidomide—leprosy	0.000279	0.00156	CcSEcCtD
Zaleplon—Headache—Thalidomide—leprosy	0.000277	0.00155	CcSEcCtD
Zaleplon—Nausea—Thalidomide—leprosy	0.000263	0.00147	CcSEcCtD
Zaleplon—TSPO—eye—leprosy	0.000243	0.0485	CbGeAlD
Zaleplon—GABRB3—eye—leprosy	0.00022	0.0441	CbGeAlD
Zaleplon—TSPO—skin of body—leprosy	0.000211	0.0422	CbGeAlD
Zaleplon—AOX1—tendon—leprosy	0.000188	0.0376	CbGeAlD
Zaleplon—TSPO—tendon—leprosy	0.000161	0.0321	CbGeAlD
Zaleplon—GABRB2—testis—leprosy	0.000157	0.0315	CbGeAlD
Zaleplon—AOX1—testis—leprosy	0.000156	0.0311	CbGeAlD
Zaleplon—GABRG2—nervous system—leprosy	0.000155	0.0309	CbGeAlD
Zaleplon—GABRB2—nervous system—leprosy	0.000155	0.0309	CbGeAlD
Zaleplon—GABRA2—nervous system—leprosy	0.000141	0.0282	CbGeAlD
Zaleplon—GABRA1—nervous system—leprosy	0.000136	0.0273	CbGeAlD
Zaleplon—TSPO—testis—leprosy	0.000133	0.0266	CbGeAlD
Zaleplon—TSPO—nervous system—leprosy	0.000131	0.0261	CbGeAlD
Zaleplon—GABRB3—testis—leprosy	0.000121	0.0242	CbGeAlD
Zaleplon—GABRB3—nervous system—leprosy	0.000119	0.0237	CbGeAlD
Zaleplon—CYP3A4—nervous system—leprosy	6.07e-05	0.0121	CbGeAlD
